Analytical Data
-
Gene name
SVEP1
- Application
-
Alternative Names
(CCP module-containing protein 22)(Polydom)(Selectin-like osteoblast-derived protein)(SEL-OB)(Serologically defined breast cancer antigen NY-BR-38)
-
Species
Human
-
Source
HEK293
-
Tag
C- hFc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q4LDE5
-
Expression Region
736-827aa
-
Molecular Weight
39.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SVEP1 (Skeletal Vascular and Embryonic Protien 1) is a member of the thrombospondin-related protein family, which plays a crucial role in various biological processes, including vascular development and bone formation. Recent studies have highlighted its potential involvement in modulating cell adhesion, migration, and signaling pathways, making it a significant focus in understanding developmental biology and tissue engineering. Notably, SVEP1 is thought to influence the extracellular matrix composition, thereby impacting cellular behavior and tissue integrity. The investigation of recombinant SVEP1 protein has gained traction, as it offers insights into its functional properties and interactions with other proteins in the extracellular matrix. Moreover, the exploration of SVEP1’s role in pathological conditions, such as fibrosis or vascular diseases, underscores its potential as a therapeutic target. By utilizing advanced techniques in molecular biology, researchers aim to unravel the complex mechanisms through which SVEP1 contributes to tissue homeostasis and disease progression, paving the way for innovative strategies in regenerative medicine and targeted therapies. Overall, the study of SVEP1 recombinant protein is pivotal for advancing our understanding of its biological significance, potentially leading to novel interventions for related diseases.
